Top Markets
Coin of the day
Inari Medical, Inc. Inari Medical, Inc.

Inari Medical, Inc.

NARI
주식 순위 #3846
Inari Medical, Inc. is a medical technology firm focused on creating,... Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis. Another key offering is FlowTriever, a substantial catheter-based aspiration and mechanical thrombectomy system, which addresses pulmonary embolism. The company also provides FlowSaver; FlowStasis, a large-bore suture retention device to manage venous access points; and FlowTriever 2, an enhanced version with a new disk design for efficiently capturing wall-adherent clots and reducing procedure time. Founded in 2011, the company was initially known as Inceptus Newco1 Inc. before rebranding as Inari Medical, Inc. in September 2013. Its corporate headquarters are located in Irvine, California.
주가
$79.97
마지막 동기화: 2025-02-19
시가총액
$4.57B
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Inari Medical, Inc. (NARI)

카테고리

Inari Medical, Inc. (NARI)의 매출
Sep 2024 기준 매출 TTM: $574.50M
Inari Medical, Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $574.50M입니다. 2022년에 회사는 $383.47M의 수익을 올렸으며 이는 2021년의 $276.98M 대비 증가입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Inari Medical, Inc.의 수익 기록 (2018 ~ 2026)
매년 말 매출
연도 매출 변화
2026 (TTM) $574.50M 16.38%
2023 $493.63M 28.73%
2022 $383.47M 38.45%
2021 $276.98M 98.31%
2020 $139.67M 173.17%
2019 $51.13M 648.70%
2018 $6.83M 0.00%
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
$46.59B 8,008.82%
US
$25.84B 4,397.32%
US
$35.48B 6,076.52%
IE
$21.00B 3,554.67%
US
- -
DE